HUE046919T2 - Terápiás szer vagy profilaktikus szer demenciára - Google Patents
Terápiás szer vagy profilaktikus szer demenciáraInfo
- Publication number
- HUE046919T2 HUE046919T2 HUE13797290A HUE13797290A HUE046919T2 HU E046919 T2 HUE046919 T2 HU E046919T2 HU E13797290 A HUE13797290 A HU E13797290A HU E13797290 A HUE13797290 A HU E13797290A HU E046919 T2 HUE046919 T2 HU E046919T2
- Authority
- HU
- Hungary
- Prior art keywords
- agent
- dementia
- prophylactic
- therapeutic agent
- therapeutic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012124336 | 2012-05-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE046919T2 true HUE046919T2 (hu) | 2020-04-28 |
Family
ID=49673425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE13797290A HUE046919T2 (hu) | 2012-05-31 | 2013-05-30 | Terápiás szer vagy profilaktikus szer demenciára |
Country Status (31)
| Country | Link |
|---|---|
| US (3) | US20150183854A1 (hu) |
| EP (2) | EP3662931B1 (hu) |
| JP (3) | JP5971659B2 (hu) |
| KR (2) | KR102133610B1 (hu) |
| CN (1) | CN104602708B (hu) |
| AR (1) | AR091218A1 (hu) |
| AU (2) | AU2013268364B2 (hu) |
| BR (1) | BR112014029566A2 (hu) |
| CA (1) | CA2875205C (hu) |
| CY (1) | CY1122530T1 (hu) |
| DK (1) | DK2857039T3 (hu) |
| ES (1) | ES2763361T3 (hu) |
| HK (1) | HK1210031A1 (hu) |
| HR (1) | HRP20192267T1 (hu) |
| HU (1) | HUE046919T2 (hu) |
| IL (1) | IL235899B (hu) |
| LT (1) | LT2857039T (hu) |
| ME (1) | ME03587B (hu) |
| MX (1) | MX361128B (hu) |
| MY (1) | MY172458A (hu) |
| NZ (1) | NZ630536A (hu) |
| PH (1) | PH12014502669A1 (hu) |
| PL (1) | PL2857039T3 (hu) |
| PT (1) | PT2857039T (hu) |
| RS (1) | RS59802B1 (hu) |
| RU (1) | RU2657438C2 (hu) |
| SG (2) | SG10201805410XA (hu) |
| SI (1) | SI2857039T1 (hu) |
| TW (2) | TWI700296B (hu) |
| WO (1) | WO2013180238A1 (hu) |
| ZA (1) | ZA201409186B (hu) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2826286C (en) | 2011-01-31 | 2021-09-21 | Intellect Neurosciences Inc. | Treatment of tauopathies |
| US9506051B2 (en) * | 2011-05-20 | 2016-11-29 | Oligomerix, Inc. | Tau protease compositions and methods of use |
| MY172458A (en) * | 2012-05-31 | 2019-11-26 | Teijin Pharma Ltd | Therapeutic agent or prophylactic agent for dementia |
| JP6345655B2 (ja) | 2012-07-03 | 2018-06-20 | ワシントン・ユニバーシティＷａｓｈｉｎｇｔｏｎ Ｕｎｉｖｅｒｓｉｔｙ | タウに対する抗体 |
| TW202136296A (zh) | 2014-06-27 | 2021-10-01 | 美商Ｃ２Ｎ醫療診斷有限責任公司 | 人類化抗-tau抗體 |
| WO2017189963A1 (en) * | 2016-04-29 | 2017-11-02 | Voyager Therapeutics, Inc. | Compositions for the treatment of disease |
| EP3519820B1 (en) * | 2016-09-30 | 2020-12-09 | H. Hoffnabb-La Roche Ag | Spr-based dual-binding assay for the functional analysis of multispecific molecules |
| WO2018152359A1 (en) | 2017-02-17 | 2018-08-23 | Denali Therapeutics Inc. | Anti-tau antibodies and methods of use thereof |
| JP2018139530A (ja) | 2017-02-27 | 2018-09-13 | 帝人ファーマ株式会社 | 認知症治療又は予防のためのヒト化抗体及びその製造方法、並びにそれを用いた認知症治療剤又は予防剤 |
| AR112600A1 (es) | 2017-05-30 | 2019-11-20 | Teijin Pharma Ltd | Anticuerpo anti-receptor de igf-i |
| AU2018345523B2 (en) | 2017-10-02 | 2021-10-21 | Merck Sharp & Dohme Llc | Chromane monobactam compounds for the treatment of bacterial infections |
| TWI809562B (zh) | 2017-10-16 | 2023-07-21 | 日商衛材R&D企管股份有限公司 | 抗tau抗體及其用途 |
| AR114472A1 (es) | 2018-04-06 | 2020-09-09 | Teijin Pharma Ltd | Anticuerpo neutralizante de spns2 |
| US20210230598A1 (en) * | 2018-07-04 | 2021-07-29 | National University Corporation Tokai National Higher Education And Research System | Oligonucleotides for controlling tau splicing, and uses thereof |
| CN110028583B (zh) * | 2019-05-07 | 2020-09-11 | 温州医科大学 | 抗Tau抗体及其在治疗阿尔茨海默病、创伤性脑损伤中的应用 |
| JP7429404B2 (ja) * | 2019-08-06 | 2024-02-08 | 慶應義塾 | タウ関連疾患モデルの製造方法 |
| JPWO2021065306A1 (hu) | 2019-09-30 | 2021-04-08 | ||
| US20230137434A1 (en) * | 2020-03-19 | 2023-05-04 | Vascular Biosciences | CAR Peptide for Improved Coronavirus Survival |
| MX2022016322A (es) | 2020-06-25 | 2023-01-24 | Merck Sharp & Dohme Llc | Anticuerpos de alta afinidad dirigidos a tau fosforilada en la serina 413. |
| WO2023092004A1 (en) | 2021-11-17 | 2023-05-25 | Voyager Therapeutics, Inc. | Compositions and methods for the treatment of tau-related disorders |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS587390B2 (ja) | 1975-03-11 | 1983-02-09 | ツキシマキカイ カブシキガイシヤ | ア−クヨウセツホウホウ |
| JP3587390B2 (ja) | 1994-03-17 | 2004-11-10 | タカラバイオ株式会社 | リン酸化アミノ酸誘導体及びリン酸化ペプチド合成方法 |
| US20020086009A1 (en) * | 1996-03-13 | 2002-07-04 | Koichi Ishiguro | Anti-phosphorylated tau protein antibodies and methods for detecting alzheimer`s disease with the use of the same |
| US20080199471A1 (en) * | 2002-03-01 | 2008-08-21 | Bernett Matthew J | Optimized cd40 antibodies and methods of using the same |
| US8012936B2 (en) | 2006-03-29 | 2011-09-06 | New York University | Tau fragments for immunotherapy |
| US20070280935A1 (en) * | 2006-04-07 | 2007-12-06 | Bernd Bohrmann | Antibody that recognizes phosphorylated peptides |
| US20080076145A1 (en) * | 2006-06-16 | 2008-03-27 | En Vivo Pharmaceuticals, Inc. | Transgenic flies expressing tau and amyloid precursor fragment |
| UA107571C2 (xx) * | 2009-04-03 | 2015-01-26 | Фармацевтична композиція | |
| EP2440234A4 (en) * | 2009-06-10 | 2013-11-06 | Univ New York | IMMUNOLOGICAL TARGETING OF PATHOLOGICAL TAU PROTEINS |
| US8609097B2 (en) | 2009-06-10 | 2013-12-17 | Hoffmann-La Roche Inc. | Use of an anti-Tau pS422 antibody for the treatment of brain diseases |
| CA2826286C (en) * | 2011-01-31 | 2021-09-21 | Intellect Neurosciences Inc. | Treatment of tauopathies |
| TR201102696U (tr) * | 2011-05-27 | 2011-06-21 | Turhal Sal�H | Bağlantısız hareketli ürün reklam standı. |
| MY172458A (en) * | 2012-05-31 | 2019-11-26 | Teijin Pharma Ltd | Therapeutic agent or prophylactic agent for dementia |
-
2013
- 2013-05-30 MY MYPI2014703534A patent/MY172458A/en unknown
- 2013-05-30 RU RU2014153099A patent/RU2657438C2/ru active
- 2013-05-30 SI SI201331636T patent/SI2857039T1/sl unknown
- 2013-05-30 CA CA2875205A patent/CA2875205C/en active Active
- 2013-05-30 KR KR1020147035417A patent/KR102133610B1/ko active IP Right Grant
- 2013-05-30 HU HUE13797290A patent/HUE046919T2/hu unknown
- 2013-05-30 KR KR1020207007010A patent/KR102208283B1/ko active IP Right Grant
- 2013-05-30 SG SG10201805410XA patent/SG10201805410XA/en unknown
- 2013-05-30 WO PCT/JP2013/065090 patent/WO2013180238A1/ja active Application Filing
- 2013-05-30 ES ES13797290T patent/ES2763361T3/es active Active
- 2013-05-30 RS RS20191640A patent/RS59802B1/sr unknown
- 2013-05-30 AU AU2013268364A patent/AU2013268364B2/en active Active
- 2013-05-30 PL PL13797290T patent/PL2857039T3/pl unknown
- 2013-05-30 DK DK13797290.7T patent/DK2857039T3/da active
- 2013-05-30 LT LTEP13797290.7T patent/LT2857039T/lt unknown
- 2013-05-30 TW TW102119176A patent/TWI700296B/zh active
- 2013-05-30 TW TW109121902A patent/TWI777183B/zh active
- 2013-05-30 EP EP19207405.2A patent/EP3662931B1/en active Active
- 2013-05-30 SG SG11201407878VA patent/SG11201407878VA/en unknown
- 2013-05-30 MX MX2014014187A patent/MX361128B/es active IP Right Grant
- 2013-05-30 JP JP2014518734A patent/JP5971659B2/ja active Active
- 2013-05-30 EP EP13797290.7A patent/EP2857039B1/en active Active
- 2013-05-30 US US14/403,803 patent/US20150183854A1/en not_active Abandoned
- 2013-05-30 CN CN201380040658.9A patent/CN104602708B/zh active Active
- 2013-05-30 BR BR112014029566A patent/BR112014029566A2/pt not_active Application Discontinuation
- 2013-05-30 NZ NZ630536A patent/NZ630536A/en unknown
- 2013-05-30 ME MEP-2019-341A patent/ME03587B/me unknown
- 2013-05-30 PT PT137972907T patent/PT2857039T/pt unknown
- 2013-05-30 AR ARP130101907 patent/AR091218A1/es active IP Right Grant
-
2014
- 2014-11-25 IL IL235899A patent/IL235899B/en active IP Right Grant
- 2014-11-28 PH PH12014502669A patent/PH12014502669A1/en unknown
- 2014-12-12 ZA ZA2014/09186A patent/ZA201409186B/en unknown
-
2015
- 2015-11-03 HK HK15110820.8A patent/HK1210031A1/xx unknown
-
2016
- 2016-05-09 JP JP2016094112A patent/JP6406678B2/ja active Active
-
2018
- 2018-01-18 AU AU2018200413A patent/AU2018200413B2/en active Active
- 2018-03-19 JP JP2018051046A patent/JP6620829B2/ja active Active
-
2019
- 2019-06-10 US US16/436,301 patent/US20200148753A1/en not_active Abandoned
- 2019-12-13 CY CY20191101311T patent/CY1122530T1/el unknown
- 2019-12-17 HR HRP20192267TT patent/HRP20192267T1/hr unknown
-
2021
- 2021-12-01 US US17/539,926 patent/US20220340646A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1210031A1 (en) | Therapeutic agent or prophylactic agent for dementia | |
| HK1211475A1 (en) | Combination therapy | |
| PL3153144T3 (pl) | Urządzenie izolacyjne | |
| SG11201501173SA (en) | PI3Kδ INHIBITOR | |
| HK1216297A1 (zh) | 腫瘤溶解綜合征的治療藥和預防藥 | |
| HK1208628A1 (en) | Prophylactic or therapeutic agent for hepatic diseases | |
| EP2823830A4 (en) | MESH-HIGHNESS MEDIUM | |
| EP2671585A4 (en) | THERAPEUTIC OR PROPHYLACTIC AGGREGATE AGAINST CACHEXIA | |
| SG11201500074XA (en) | Safety cabinet | |
| GB201217439D0 (en) | Combination therapy | |
| EP2925877A4 (en) | milling | |
| EP2925876A4 (en) | milling | |
| PL2554541T3 (pl) | Środek terapeutyczny lub środek profilaktyczny na fibromialgię | |
| IL236450A (en) | Process for making 5-fluoro-h1-pyrazoles | |
| PL399418A1 (pl) | Sposób wytwarzania 4-metoksydihydrochalkonu | |
| PL399419A1 (pl) | Sposób wytwarzania 4-metoksydihydrochalkonu | |
| GB201207305D0 (en) | Therapy | |
| PL2677104T3 (pl) | Szafka bezpieczeństwa | |
| HK1210426A1 (en) | Combination therapy | |
| EP2925790A4 (en) | milling | |
| EP2914267A4 (en) | TREATMENT OF DARM CONSTIPATION | |
| GB2502527B (en) | Plumbing apparatus | |
| GB201214234D0 (en) | Prophylactic therapy | |
| GB201220253D0 (en) | Plumbing apparatus | |
| PL2861904T3 (pl) | Ulepszone urządzenie instalacji wodociągowej |